Enhanced nuclear factor-κB activation induced by tumour necrosis factor-α in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein

AIDS

Volumn 10, Issue 5, 1996, Pages 455-461

  Ramazzotti, Eric ^a   Vignoli, Monica ^a   Re, Maria Carla ^a   Furlini, Giuliano ^a   La Placa, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

HIV 1; Nuclear factor B activation; Tat autocrinous loop; Transactivating Tat protein

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ELECTROPHORETIC MOBILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 0029869718     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199605000-00002     Document Type: Article

References (41)

1. Jones KA, Peterlin MB: Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 1995, 63:717-743.
2. Taylor JP, Kundu M, Khalili K: TAR independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. Virology 1993, 195:780-785.
3. Huang L, Joshi A, Willey R, Orenstein J, Jeang KT: Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel transcriptional function of Tat in virion infectivity. EMBO J 1994, 13:2886-2896.
4. Mann DA, Frankel AD: Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 1991, 10:1733-1739.
5. Ensoli B, Buonaguro L, Barillari G, et al.: Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993, 67:277-287.
6. Thomas CA, Dobkin J, Weinberger OK: Tat-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells. J Immunol 1994, 153:3831-3839.
7. Buonaguro L, Barillari G, Chang HK, et al.: Effects of extracellular human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 1992, 66:7159-7167.
8. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M: Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for HIV-1 induced hematopoietic suppression. Blood 1992, 80:3036-3043.
9. Gibellini D, Zauli G, Re MC, et al.: Recombinant human immunodeficiency virus type 1 Tat protein sequentially upregulates IL-6 and TGβ-1 mRNA expression and protein synthesis in peripheral blood monocytes. Br J Haematol 1994, 88:261-267.
10. Westendorp MO, Li-Weber M, Frank MW, Krammer PH: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T-cells. J Virol 1994, 68:4177-4185.
11. Viscidi RP, Mayur K, Lederman HM, Frankel AD: Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989, 246:1606-1608.
12. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G: The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988, 335:606-611.
13. Vogel J, Hinrichs SH, Napolitano LA, Ngo L, Jay G: Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res 1991, 51:6686-6690.
14. Corallini A, Altavilla G, Pozzi L, et al.: Systemic expression of HIV tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993, 53:5569-5575.
15. Vellutini C, Horschowski N, Philippon V, Gambarelli D, Nave KH, Filippi P: Development of lymphoid hyperplasia in transgenic mice expressing the HIV-1 tat gene. AIDS Res Hum Retroviruses 1995, 11:21-29.
16. Li CJ, Wang C, Friedman DJ, Pardee AB: Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1995, 92:5461-5464.
17. Zauli G, Gibellini D, Milani D, et al.: Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial and neuronal cell lines from death by apoptosis. Cancer Res 1993, 53:4481-4485.
18. Gibellini D, Caputo A, Celeghini C, et al.: Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus type 1 (HIV-1) infection. Br J Haematol 1995, 89:24-33.
19. Li CJ, Friedman DJ, Wang C, Melelev V, Pardee AB: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268:429-431.
20. Westendorp MO, Frank R, Ochsenbauer C, et al.: Sensitization of T cell to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 1995, 375:497-500.
21. Purvis SF, Jacobberger JW, Sramkoski RM, Patki AH, Lederman MM: HIV type 1 tat protein induces apoptosis and death in Jurkat cells. AIDS Res Hum Retroviruses 1995, 11:443-450.
22. Campioni D, Corallini A, Zauli G, Possati L, Altavilla G, Barbanti Brodano G: HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res Hum Retroviruses 1995, 11:1039-1048.
23. Zauli G, La Placa M, Vignoli M, et al.: An autocrine loop of HIV-1 Tat protein responsible for the improved survival/differentiation capacity of permanently tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10:306-316.
24. Alcami J, de Lera TL, Folgueira L, et al.: Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T-lymphocytes. EMBO J 1995, 14:1552-1560.
25. Roulston A, Lin R, Beauparlant P, Wainberg MA, Hiscott J: Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factor. Microbiol Rev 1995, 59:481-505.
26. Westendorp MO, Shatrov VA, Schulze-Osthoff K, et al.: HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J 1995, 14:546-554.
27. Caputo A, Sodroski JC, Haseltine WA: Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. J Acquir Immune Defic Syndr Hum Retrovirol 1990, 3:372-379.
28. Li Y, Ross J, Scheppler JA, Franza R: An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators. Mol Cell Biol 1991, 11:1883-1893.
29. Demarchi F, D'Agaro P, Falaschi A, Giacca M: In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J Virol 1993, 67:7450-7460.
30. Giacca M, Gutierrez MI, Menzo S, D'Adda Di Fagagna F, Falaschi A: A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. Virology 1992, 186:133-147.
31. Ensoli B, Gendelman R, Markham P, et al.: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 371:674-680.
32. Kolson DL, Buchhalter J, Collman R, et al.: HIV-1 Tat alter normal organization of neurones and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res Hum Retroviruses 1993, 9:677-685.
33. 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 1993, 121:461-468.
34. Haskill S, Beg AA, Tompkins SM, et al.: Characterization of an immediate early antigen gene induced in adherent monocytes that encodes IκB-like activity. Cell 1991, 65:1281-1289.
35. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994, 12:141-179.
36. Lofquist AK, Mondal K, Morris JS, Haskill JS: Transcription independent turnover of IκBα during monocyte adherence: implications for a transcriptional component regulating IκBα/MAD-3 mRNA levels. Mol Cell Biol 1995, 15:1737-1746.
37. Luznick L, Kraus G, Guatelli J, Richman D, Wong-Staal F: Tat-independent replication of human immunodeficiency viruses. J Clin Invest 1995, 95:328-332.
38. Tong-Starksen SE, Baur A, Lu XB, Peck E, Paterlin BM: Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs. Virology 1993, 195:826-830.
39. Kim YS, Panganiban AT: The full-length Tat protein is required for Tar-independent post-transcriptional trans activation of human immunodeficiency virus type 1 env gene expression. J Virol 1993, 67:3739-3747.
40. Steinaa L, Soresen AM, Nielsen JO, Hansen JES: Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch Virol 1994, 139:263-271.
41. Re MC, Furlini G, Vignoli M, Zauli G, La Placa M: Antibody against HIV-1 tat protein may have influenced the progression of human immunodeficiency virus type 1 (HIV-1) disease in HIV-1 infected haemophiliac patients. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10:408-416.